Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2010

View Archived Issues

Scientists identify LEDGINs inhibiting LEDGF-integrase interaction and HIV replication

Cerenis and Novasep receive French government funds to develop CER-001

Preclinical data presented on new vaccines against tick-borne encephalitis

In vivo data support benefit of AM-966 for treatment of lung fibrosis

IRX-1 gene methylation in plasma is a potential biomarker of gastric cancer

VRS-859 improves glycemic control in preclinical studies

Cynapsus acquires license option for Adagio's PD therapeutic APL-130277

Dynavax completes first immunizations in universal flu vaccine trial

SurModics and EGEN continue siRNA delivery collaboration

Genzyme updates progress of second quarter 2010

Merck KGaA claims new Src kinase inhibitors

New Met kinase inhibitors disclosed by Merck KGaA

Antares reports phase III data on Anturol gel for overactive bladder

Boehringer Ingelheim presents new 5-HT2B receptor antagonists

Bayer Schering Pharma identifies new sGC activators

Bayer Schering Pharma discovers new HNE inhibitors

Enrollment begins in phase IIb OMS-302 trial in subjects undergoing cataract surgery

FDA grants priority review status to cladribine tablets NDA for multiple sclerosis

Sativex approved in Spain as add-on therapy for multiple sclerosis spasticity

Covidien completes tender offer for all outstanding Somanetics shares

Astellas extends license of Regeneron's VelocImmune technology

AbD Serotec licenses PTH-targeting diagnostic antibody from UCL Business

Transdel set to partner Ketotransdel

Marina Biotech and University of Helsinki extend collaboration

GE begins study to improve treatment selection in early-stage colon cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...